New online platform

We have released our new online platform developed to determine the advantage of chemotherapy in breast cancer by using AI methods and clinico-pathological data

We have released our new online platform developed to determine the advantage of chemotherapy in breast cancer by using AI methods and clinico-pathological data

Our epigenetic review desrcibing the methyaltion-based biomarkers in colorectal cancer has reached highly cited status in the Web of Science.

Menyhart O et al.: Dietary approaches for exploiting metabolic vulnerabilities in cancer. BBA Reviews on Cancer (2024)

Bartha A et al.: Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response, Eur J Cancer (2023)

Győrffy B: Transcriptome-level Discovery of Survival-Associated Biomarkers and Therapy Targets in Non-Small-Cell Lung Cancer, Brit J Pharmacol (2023)

Wang XQ, Győrffy B, Bianchinig G, Ali RH et al: Single-cell spatial predictors of immunotherapy response in triple negative breast cancer, Nature (2023)
Our manuscript desrcibing the multipletesting.com platform has reached highly cited status in Web of Science.

Szluka P, Csajbók E, Győrffy B: Relationship between bibliometric indicators and university ranking positions, Scientific Reports (2023)
Copyright 2025. All rights reserved
Designed by Zymphonies